欢迎访问ProbeChem中文网站,英文网站请访问www.probechem.com

首页-小分子抑制剂&激动剂-PI3K/Akt/mTOR Pathway-Akt-Afuresertib
Afuresertib

Chemical Structure : Afuresertib

CAS No.: 1047644-62-1

Afuresertib (GSK 2110183, GSK2110183, LAE002)

货号: PC-44664Not For Human Use, Lab Use Only.

Afuresertib (GSK2110183) is a potent, selective, ATP-competitive pan-AKT inhibitor with biochemical IC50 of 0.08/2/2.6 nM for AKT1/2/3.

规格 价格 库存 数量
5 mg ¥980 In stock
10 mg ¥1480 In stock
25 mg ¥2580 In stock
50 mg ¥3980 In stock
100 mg Get quote

大包装,大折扣!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

纯度 & COA & 质检文件 纯度: >98% (HPLC) Select Batch:

生物&药学活性

Afuresertib (GSK2110183) is a potent, selective, ATP-competitive pan-AKT inhibitor with biochemical IC50 of 0.08/2/2.6 nM for AKT1/2/3.
Afuresertib (GSK2110183) also inhibits PKA (IC50=1.3 nM) and AKT1 E17K mutant (IC50=0.2 nM), selective over PKC, PKG isoforms and p70S6K.
Afuresertib (GSK2110183) is orally bioactive.

物理化学性质&存储条件

分子量 427.3232
分子式 C18H17Cl2FN4OS
外观性状 Solid
CAS No.
储存条件
固体粉末
-20 °C 12 个月; 4°C 6 个月
配置液
-80 °C 6 个月; -20°C 6 个月
Shipping
Solubility

DMSO: ≥ 40 mg/mL

Chemical Name/SMILES

2-Thiophenecarboxamide, N-[(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-

参考文献

1. Dumble M, et al. PLoS One. 2014 Jun 30;9(6):e100880.

2. Spencer A, et al. Blood. 2014 Oct 2;124(14):2190-5.

3. Arceci RJ, et al. Pediatr Blood Cancer. 2017 May;64(5).

备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

联系我们 sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

询单

  • *产品名称:
  • *姓名:
  • *邮箱:
  • *公司名称:
  • *询单数量:
  • *国籍:
  • 询单信息: